News and Trends 30 May 2023
New study reveals Alzheimer’s inflammation protection
A possible explanation has been found in a study for why apoE4, the most significant genetic risk factor associated with…
News and Trends
- Latest Posts
News and Trends 30 May 2023
Pancreatic cancer microbiome discovery holds treatment hope
iNtRON Biotechnology has announced the identification of prophage and (non-) ORF-jamphage from the microbiome frequently observed in long-term pancreatic cancer…
News and Trends 30 May 2023
Potential targets against natural killer/T-cell lymphoma found
A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS)…
News and Trends 30 May 2023
Researchers identify gene expression signature to predict progression of type 1 diabetes
Researchers from Turku Bioscience Centre and InFLAMES Flagship at the University of Turku in Finland, have identified a gene expression…
ADVERTISEMENT
News and Trends 30 May 2023
Molecular Partners presenting positive solid tumor data
Molecular Partners AG will present additional positive data from the ongoing phase 1 study of MP0317, a CD40 agonist designed…
News and Trends 30 May 2023
UK invests £650M in life sciences
A £650 million ($804 million) war-chest to boost the U.K.’s life sciences sector has been announced. The ‘Life Sci for…
News and Trends 26 May 2023
VarmX raises €30M for blood clotting trial
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, has successfully raised an…
News and Trends 26 May 2023
Novartis buys AVROBIO cystinosis gene therapy program for $87.5M
AVROBIO, Inc., a clinical-stage gene therapy company working to free people from a lifetime of genetic disease, has agreed to…
News and Trends 26 May 2023
Rocket Pharmaceuticals receives FDA designation for pyruvate kinase deficiency gene therapy
Rocket Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT)…
News and Trends 26 May 2023
Transgene and BioInvent report positive solid tumor results
Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB, a biotech company focused…
ADVERTISEMENT
News and Trends 25 May 2023
PharmEnable raises $7.5M to develop small molecule drugs to treat cancer and neurological diseases
PharmEnable, a drug discovery company focused on chemical novelty, diversity and complexity, announces it has closed a Pre-Series A investment…
News and Trends 25 May 2023
Researchers discover genetic variation offers Alzheimer’s disease clues
A new study conducted by researchers at the University of Eastern Finland discovered that the APP A673T genetic variant, which…
News and Trends 24 May 2023
smartbax raises €1.2M to create next-generation antibiotics
smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the close of its seed financing round…
News and Trends 24 May 2023
Major progress as Swedish scientists get brain tumors to self destruct
Researchers at the University of Gothenburg in Sweden, working with French colleagues, have successfully developed a method able to kill…
News and Trends 23 May 2023
FDA approval for Rznomics’ glioblastoma treatment trial
Rznomics Inc., a South Korea based biopharmaceutical company specializing in the development of RNA-based gene therapeutics, has received phase 1/2a…
News and Trends 23 May 2023
AMR research gets £39m shot from UK government
Research initiatives to develop new treatments to tackle antimicrobial resistance (AMR) – known as the “silent killer” – will receive…
ADVERTISEMENT
News and Trends 23 May 2023
Vicore reports new data from idiopathic pulmonary fibrosis study
Vicore Pharma Holding AB (publ), has announced an updated interim analysis of its AIR phase 2a trial with C21 in…
News and Trends 23 May 2023
HuidaGene Therapeutics creates world’s first ‘G to Y’ DNA base-editor
HuidaGene Therapeutics, a clinical-stage genome-editing company, says the National Science Review has published data from its study of the world's…
News and Trends 23 May 2023
Ironwood acquires VectivBio in $1B deal
Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, and VectivBio Holding AG, a clinical-stage biopharmaceutical company pioneering novel, transformational treatments for…
News and Trends 23 May 2023
Take part in a clinical trial? Sure, just pay me
The majority of people in the U.K. (68%) would consider taking part in a clinical trial, it has been revealed…
